Financials
- Market Capitalization 3.08 M
- Employee 2
- Founded 2007
- CEO N/A
- Website www.propanc.com
- Headquarter Delaware, United States
- FIGI BBG002086386
- Industry 医薬品メーカー(一般)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.29
売上高対価格比率
-439.06
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4899 | KAPA Kairos Pharma, Ltd. Common Stock | 0.24 USD | 0.00% | 0.00% | -17.24% | -58.62% | 5.69 M USD | ||
| 4966 | VIVS VivoSim Labs, Inc. - Common Stock | 0.29 USD | 0.00% | +3.57% | -14.71% | -84.82% | 4.31 M USD | ||
| 5039 | VBIO Valion Bio, Inc. - Common stock | 0.12 USD | 0.00% | -14.29% | -55.56% | -90.00% | 2.66 M USD | ||
| 5066 | DCOY Decoy Therapeutics Inc. - Common Stock | 2.90 USD | -2.36% | -9.94% | -30.46% | +258.56% | 1.90 M USD |